Shares of CEVA Inc. plunged 12.1% to $34.00 Monday morning after the chip-design licensor's second-quarter earnings exposed a widening gap between deal-signing momentum and actual product revenue. The company reported $0.08 EPS, beating the consensus estimate of $0.07 by a penny , but investors focused squarely on what the beat didn't fix.
Licensing Is Booming, but the Royalty Engine Barely Moved
Total revenue hit $29.0 million, up 13%, with licensing and related revenue reaching $18.2 million — up 21% and the highest in three years. That's the good news. The bad: royalty revenue — the recurring stream CEVA collects on every chip shipped using its designs — rose just 1% year over year to $10.8 million . Licensing shows future demand; royalties show present demand. The typical lag between signing a license and collecting royalties is 18 to 36 months , meaning today's deals won't pay off until 2028. Investors who bid CEVA to a $51.60 52-week high last month were pricing in a faster conversion, and the 1% royalty print shattered that timeline.
The COO's Exit Rattles an Already Fragile Narrative
COO Michael Boukaya agreed to resign effective August 1, 2026, though he will remain through year-end to support the transition.
Boukaya oversaw all R&D and marketing for CEVA's hardware and software platforms — the very engine behind its AI and wireless product roadmap. Investors must now trust that CEVA can convert high-profile licensing wins into sustainable royalty growth despite ongoing losses and customer-concentration risk — and do so without the executive who architected those products.
Analyst Targets Now Hang Far Above the Stock Price
Stifel raised its price target to $50 in July, Needham initiated at $55 citing "Physical AI potential," and UBS set a $48 target — all well above today's $34.00. Stifel cited an AI royalty stream "expected to become meaningful beginning in 2027" and views 2026 as a transition year . The disconnect is stark: Wall Street is modeling a future that Monday's royalty number suggests may arrive later than expected.
Margins Improved, but Can't Paper Over the Core Concern
Non-GAAP operating income rose to $3.1 million with an 11% margin, up from $0.8 million and 3% a year ago. That's real progress. But for a stock that had nearly tripled off its 52-week low, the market demanded proof that licensing momentum was translating into shipped-chip royalties — and didn't get it.